Does Rallies show Form 4 insider transactions for ITRM?

Yes. Rallies tracks ITRM insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is ITRM research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ITRM. It does not provide personalized investment advice.

ITRM (Iterum Therapeutics plc Ordinary Share) Stock Analysis - Insider Trades

Iterum Therapeutics plc Ordinary Share (ITRM) is a publicly traded Healthcare sector company. As of May 21, 2026, ITRM trades at $0.03 with a market cap of $1.60M and a P/E ratio of -0.04. ITRM moved -28.57% today. Year to date, ITRM is -94.99%; over the trailing twelve months it is -97.56%. Its 52-week range spans $0.03 to $3.02. Analyst consensus is hold with an average price target of $0.00. Rallies surfaces ITRM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading ITRM stock inside the company?

Recent ITRM insider activity includes Dunne Michael W. bought 6.00K, Dunne Michael W. bought 15.00K, Dunne Michael W. bought 25.00K, Dunne Michael W. bought 10.00K, and Dunne Michael W. bought 20.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

ITRM Key Metrics

Key financial metrics for ITRM
Metric	Value
Price	$0.03
Market Cap	$1.60M
P/E Ratio	-0.04
EPS	$-0.72
Dividend Yield	0.00%
52-Week High	$3.02
52-Week Low	$0.03
Volume	65.74M
Avg Volume	0
Revenue (TTM)	$390.00K
Net Income	$-26.96M
Gross Margin	0.00%

Recent ITRM Insider Trades

Dunne Michael W. bought 6.00K (~$2.19K) on Nov 18, 2025.
Dunne Michael W. bought 15.00K (~$10.85K) on Aug 8, 2025.
Dunne Michael W. bought 25.00K (~$35.00K) on Dec 22, 2023.
Dunne Michael W. bought 10.00K (~$18.44K) on Dec 18, 2023.
Dunne Michael W. bought 20.00K (~$40.69K) on Nov 22, 2023.

Latest ITRM News

Iterum Therapeutics Files Irish Winding-Up Petition, Hearing Set April 13 — Mar 27, 2026
Iterum Secures Medicare Part D Deal Covering 3.5M Lives, Gains Patent Expiring 2039 — Feb 13, 2026

ITRM Analyst Consensus

1 analysts cover ITRM: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is hold. Average price target: $0.00.

Common questions about ITRM

Who is trading ITRM stock inside the company?: Recent ITRM insider activity includes Dunne Michael W. bought 6.00K, Dunne Michael W. bought 15.00K, Dunne Michael W. bought 25.00K, Dunne Michael W. bought 10.00K, and Dunne Michael W. bought 20.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for ITRM?: Yes. Rallies tracks ITRM insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is ITRM research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ITRM. It does not provide personalized investment advice.